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Since the early reports of increased deaths from
cardiopulmonary disease (CPD) after serious
air pollution episodes (Firket 1931; Logan
1953), studies both within the United States
and abroad have found similar short-term
effects of air pollution (Dominici et al. 2003;
Samet et al. 2000; Zanobetti et al. 2003).
Studies have also found increased risk of
CPD, noncancer respiratory, and respiratory
cancer deaths with chronic exposure to ambi-
ent particulate matter (PM) (Abbey et al.
1999; Dockery et al. 1993; McDonnell et al.
2000; Pope et al. 1995, 2002, 2004a), black
smoke (NOx) (Hoek et al. 2002), and nitro-
gen oxides (Hoek et al. 2002; Nafstad et al.
2004). Four main prospective studies have
been conducted in the United States to assess
long-term health effects of ambient air pollu-
tion in adults [the Six Cities Study, the
American Cancer Society (ACS) study, the
Adventist Health Study on the Health Effects
of Smog (AHSMOG), and the national
cohort of male U.S. veterans]. Associations
with ﬁne particulates [PM < 2.5 µm in aero-
dynamic diameter (PM2.5)] have been found
for all-cause mortality, CPD mortality, and
respiratory/lung cancer mortality in the ACS,
Six Cities, and AHSMOG studies and with
mortality attributable to ischemic heart disease
(IHD), dysrhythmias, heart failure, and car-
diac arrest in the ACS study. AHSMOG
(Abbey et al. 1999) has also shown positive
associations, although not always signiﬁcant,
between PM < 10 µm in aerodynamic diame-
ter (PM10) and all-natural-cause mortality and
CPD mortality in males but not in females.
For fatal lung cancer and any mention of non-
malignant respiratory disease, a positive associ-
ation was found with PM10 in both sexes. The
national cohort of male U.S. veterans, where
all subjects were hypertensive at baseline,
found no increased mortality with increasing
levels of ﬁne particulates (Lipfert et al. 2000).
From Europe, Hoek et al. (2002) reported
increased risk of CPD mortality and all-cause
mortality with increased concentrations of
black smoke and nitrogen dioxide, and
Nafstad et al. (2004) found increased risk of
noncancer respiratory mortality and CPD
mortality with increasing levels of NOx.
Several studies on short-term effects have
found that ambient PM increases cardiac
arrhythmia (Peters et al. 2000), decreases heart
rate variability (Pope et al. 2004b), increases
the inflammatory response measured by
C-reactive protein (CRP) (Riediker et al.
2004), and increases blood viscosity (Peters
et al. 1997) as well as other blood markers
(e.g., hemoglobin, ﬁbrinogen, platelet counts,
white cell counts) (Riediker et al. 2004). These
observed effects would provide a mechanism
by which chronic exposure to ambient air pol-
lution is associated with risk of coronary heart
disease (CHD).
This study reports on the risk of fatal
CHD associated with long-term ambient air
pollution in AHSMOG.
Materials and Methods
Study population. AHSMOG began in April
1977 by enrolling 6,338 participants from the
Adventist Health Study (AHS) (n = 34,198), a
large cohort study of the relationship between
lifestyle and risk of chronic disease (Beeson
et al. 1989). To be included in AHSMOG,
subjects must be nonsmoking, non-Hispanic
whites ≥ 25 years of age at baseline and must
have lived ≥ 10 years within 5 miles of their
1976 neighborhood. All subjects satisfying
these criteria were selected from three large
metropolitan areas in California: San Francisco,
South Coast (i.e., Los Angeles and eastward),
and San Diego air basins. In addition, a 13%
random sample of 862 AHS subjects was
selected from the rest of California assuring
large variation and wide ranges in concentra-
tions of different ambient air pollutants.
As part of their enrollment in the AHS in
1976, all participants completed a compre-
hensive questionnaire that included questions
on education, anthropometric data, smoking
history, dietary habits, exercise patterns, and
previous physician-diagnosed chronic diseases
(Beeson et al. 1989). Monthly residence and
work location histories were obtained for each
subject for the period January 1966 through
December 1998, or until date of death or
date of last contact, by using mailed question-
naires (1977, 1987, 1992, 2000), tracing by
telephone, and interviewing of surrogates (for
deceased subjects). Only 29 (< 0.01%) per-
sons were lost to follow-up with respect to
vital status, and these were censored at date of
last contact for inclusion in risk sets. The fol-
low-up questionnaires contained standardized
questions on respiratory symptoms (American
Thoracic Society 1995) and questions to
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The purpose of this study was to assess the effect of long-term ambient particulate matter (PM)
on risk of fatal coronary heart disease (CHD). A cohort of 3,239 nonsmoking, non-Hispanic
white adults was followed for 22 years. Monthly concentrations of ambient air pollutants were
obtained from monitoring stations [PM < 10 µm in aerodynamic diameter (PM10), ozone, sulfur
dioxide, nitrogen dioxide] or airport visibility data [PM < 2.5 µm in aerodynamic diameter
(PM2.5)] and interpolated to ZIP code centroids of work and residence locations. All participants
had completed a detailed lifestyle questionnaire at baseline (1976), and follow-up information on
environmental tobacco smoke and other personal sources of air pollution were available from four
subsequent questionnaires from 1977 through 2000. Persons with prevalent CHD, stroke, or dia-
betes at baseline (1976) were excluded, and analyses were controlled for a number of potential
confounders, including lifestyle. In females, the relative risk (RR) for fatal CHD with each
10-µg/m3 increase in PM2.5 was 1.42 [95% confidence interval (CI), 1.06–1.90] in the single-
pollutant model and 2.00 (95% CI, 1.51–2.64) in the two-pollutant model with O3.
Corresponding RRs for a 10-µg/m3 increase in PM10-2.5 and PM10 were 1.62 and 1.45, respec-
tively, in all females and 1.85 and 1.52 in postmenopausal females. No associations were found in
males. A positive association with fatal CHD was found with all three PM fractions in females but
not in males. The risk estimates were strengthened when adjusting for gaseous pollutants, espe-
cially O3, and were highest for PM2.5. These ﬁndings could have great implications for policy reg-
ulations. Key words: air pollution, coronary disease, ischemic heart disease, long-term exposure,
mortality, particulate matter. Environ Health Perspect 113:1723–1729 (2005).
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pertinent to relative exposure to ambient air
pollutants, as well as occupational exposures
to dust and fumes and indoor sources of air
pollution, including environmental tobacco
smoke (ETS).
Several air pollutants were estimated for
study participants using the statewide net-
work of monitoring stations maintained by
the California Air Resource Board (CARB)
(Abbey et al. 1991). Because estimated PM2.5
measures were not available on a statewide
basis during follow-up, only the 3,769 (2,422
females and 1,347 males) belonging to the
airport subcohort (those who lived within an
airshed adjacent to one of nine California
airports with available visibility measures:
Alameda, Bakersfield, Fresno, Long Beach,
Los Angeles, Ontario, Sacramento, San Jose,
and San Diego) were included in this study.
Of these, 530 (n = 332 females, n = 198 males)
were excluded because of a history of CHD,
stroke, or diabetes at baseline, leaving 3,239
subjects for analyses.
Estimation of ambient air pollution con-
centrations. Estimates of monthly ambient
concentrations of PM10, ozone, sulfur dioxide,
and NO2 were formed for study participants
for 1973–1998 using fixed-site monitoring
stations maintained by CARB. The detailed
methods for estimating ambient air pollutants
for study participants are described elsewhere
(Abbey et al. 1991, 1995a). Brieﬂy, monthly
indices of ambient air pollutant concentrations
at 348 monitoring stations throughout
California were interpolated to geographic
ZIP code centroids according to home and
work location histories of study participants.
These were cumulated and then averaged over
time. Interpolations were restricted to ZIP
code centroids within 50 km of a monitoring
station and were not allowed to cross barriers
to airflow or other topographic obstructions
> 250 m above the surrounding terrain.
Concentrations of PM10 before 1987 were
estimated using site- and season-specific
regressions based on total suspended particles
(TSPs) (Abbey et al. 1995a). Since 1987,
directly monitored PM10 has been used.
Daily estimates of ambient PM2.5 concen-
tration were obtained for 11 airsheds from
daily measures of visibility collected at the nine
California airports for the years 1973–1998
using regression equations relating PM2.5 and
visibility. Because of wind patterns, Ontario
provided three separate airsheds (East, West,
Central). Detailed methods for PM2.5 estima-
tion have been described previously (Abbey
et al. 1995b). Individual monthly average
PM2.5 concentrations were calculated as the
mean of the daily ambient PM2.5 estimates for
the airshed in which the participant resided.
Any month with PM2.5 estimates for > 75% of
the days was considered to have valid data.
Ascertainment of deaths. Fatal CHD,
deﬁned by codes 410–414 of the International
Classiﬁcation of Diseases, 9th Revision (ICD-9)
(World Health Organization 1977) as either
“deﬁnite fatal myocardial infarction” or “other
deﬁnite fatal CHD,” as underlying or immedi-
ate cause of death was used to assess fatal CHD.
Deaths were ascertained through 1998
using record linkage with both the California
death certiﬁcate ﬁles and the National Death
Index (Centers for Disease Control and
Prevention, National Center for Health
Statistics, Atlanta, GA, USA). In addition, our
tracing procedures, which included church
records, were used (Beeson et al. 1989). Thus,
among the airport subcohort free of CHD,
stroke, and diabetes at baseline, we identiﬁed
1,054 total deaths during follow-up. Death
certiﬁcates were obtained, and a state-certiﬁed
nosologist, blinded to the exposure status,
coded each death certiﬁcate according to the
ICD-9 codes.
Statistical analysis. Sex-specific compar-
isons of baseline descriptive information
between CHD mortality cases and noncases
were made using the Student t-test or chi-
square test.
Time-dependent Cox proportional-
hazards regression modeling was used to
study associations between pollutants (PM2.5,
PM10–2.5, PM10, O3, SO2, and NO2) and
CHD mortality with attained age as the time
variable (Greenland 1989). This was further
augmented by adding the sandwich variance
estimate (Lin 1994) to adjust for correlated
observations within each airshed. All 11 air-
sheds around the nine airports were included
in the model. We also included the airports as
dummy variables stratified with the Cox
model. Rate ratios were calculated for an
increment of 10 µg/m3 for each of the par-
ticulate pollutants and 10 ppb for each of
gaseous pollutants, except SO2, which was
calculated for an increment of 1 ppb. Because
measures for most of the pollutants were
available only from 1973, we had 4-year
monthly averages for these pollutants at base-
line in 1977. To standardize the exposure
window preceding events, we therefore
selected 4-year average as our moving time
period of exposure, but excluded the last
month before the event to avoid measuring
short-term effects. Participants who did not
die were censored at end of follow-up, or at
time of last contact if they were lost to follow-
up (394 females, 166 males). The different
pollutants were entered into the model as
continuous variables.
The basic multivariable model included
past cigarette smoking, body mass index
(BMI), years of education, and frequency of
meat consumption. We added an interaction
term between sex and pollutant to this basic
model that was signiﬁcant, and therefore, all
analyses were sex specific. Additional candi-
date variables for inclusion in the ﬁnal model
were ETS (years lived or worked with a
smoker), total physical activity at baseline, his-
tory of hypertension at baseline, exposure to
dust/fumes at work, frequency of eating nuts
(Fraser et al. 1992), number of glasses of water
per day (Chan et al. 2002), time spent out-
doors, and hormone replacement therapy
(HRT) (female models). In addition, we
found that the levels of PM pollutants used in
this study have declined from 1973 to 1998
(Figure 1), and we therefore included calendar
Chen et al.
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Figure 1. Mean concentration over time, 1973–1998: (A) PM2.5; (B) PM10; and (C) O3. (A and B) Sexes combined: AHSMOG cohort (solid line), Ontario East air basin
(dashed line), and San Diego air basin (dotted line). (C) AHSMOG cohort (solid line), mountain areas (dashed line), and coastal areas (dotted line). The y-axis
scales differ among the three panels.time as a candidate variable to adjust for possi-
ble changes in PM composition over time. All
candidate variables were entered into the basic
multivariable model one at a time to assess
their impact on the main effect. Only calendar
year changed the relative risks (RRs) > 10%
(actually 16%) and was retained in the final
model (Greenland 1989).
The proportional hazards assumption was
checked by examining log [–log(survival)]
curves versus the time (attained age) as well as
the product term of each respective variable in
the ﬁnal model with the log of the time vari-
able (Greenland 1989). Each of these interac-
tion terms produced a p-value > 0.05 based
on the Wald statistic, indicating that the pro-
portional hazards assumptions were not seri-
ously violated. This was supported further by
visual inspection.
The same sex-specific, time-dependent
multivariable Cox proportional-hazards regres-
sion models with and without the sandwich
variance estimate, airport dummy variables, and
stratified analysis were further used to study
associations in two-pollutant models for partic-
ulates (PM2.5, PM10–2.5, or PM10) with each of
the gases (O3, SO2, and NO2) and CHD mor-
tality. We evaluated the interactions between
two individual pollutants for inclusion in the
ﬁnal model based on whether they changed the
RRs > 10%. None of the terms met this crite-
rion (Greenland 1989). All analyses were
repeated for postmenopausal females separately.
In addition, we repeated sex-specific
analyses using cumulative monthly averages
of each particulate pollutant from 1973 to
censoring and also for each of the PM frac-
tions using three levels of exposure (≤ 25,
> 25–38, > 38 µg/m3) rather than as a contin-
uous variable. We used the SAS statistical
package (version 9.1; SAS institute, Cary,
NC) for all analyses.
Results
During 22-year follow-up (1977–1998), there
were 155 CHD deaths in females and 95
among males, 23.7% of all deaths in this group.
Those who died of CHD were older at
baseline, had fewer years of education, and were
more likely to have hypertension; a larger pro-
portion of the females were postmenopausal,
and of these, fewer had used HRT (Table 1). A
higher proportion of female noncases had lived
or worked with a smoker (ETS), and noncases
tended to drink more water than did cases. The
mean concentrations and correlations of pollu-
tants for this airport subcohort from 1973
through the month of censoring are provided in
Table 2. Frequency histograms of the individual
mean ambient concentrations of each of the PM
fractions from 1973 to censoring month are
given in Figure 2. Those in the lowest distribu-
tion of PM2.5 lived in the airsheds represented
by the San Diego, San Jose, Sacramento, and
Alameda airports; medium levels were found in
Fresno, Los Angeles International, Bakersﬁeld,
Long Beach, Ontario West, and Ontario
Central; and the highest distribution represents
Ontario East. Figure 1 shows the secular trends
in PM10, PM2.5, and O3 during the study for
the Ontario East and San Diego air basins and
for the study population as a whole.
Risk of fatal CHD. All results presented
are from the time-dependent Cox model
without and with the inclusion of the sand-
wich variance estimate. For females, in age-
adjusted single-pollutant models, a positive
but nonsignificant relationship was found
between each of the three PM fractions and
risk of fatal CHD (Table 3). This association
became stronger in multivariate analyses, with
PM2.5 having the highest RR of 1.42 [95%
conﬁdence interval (CI), 1.11–1.81] for each
increment of 10 µg/m3.
In two-pollutant models with O3 (Table 4),
the associations with each of the PM fractions
became stronger and statistically significant
both in age-adjusted and in multivariable-
adjusted models, with the strongest relationship
for PM2.5 (RR = 1.99; 95% CI, 1.37–2.88).
NO2 did not change the associations between
PM and fatal CHD, whereas SO2 strength-
ened the association some, but not to the same
degree as did O3. Point estimates remained
virtually unchanged both in single-pollutant
and in multipollutant models when including
the sandwich variance estimate. When airports
were included as dummy variables or in
stratified analyses, the risk estimates either
remained the same or were strengthened.
Limiting the analyses to postmenopausal
females resulted in small increases in risk
estimates.
Using cumulative monthly averages from
1973 to censoring instead of the 4-year mov-
ing average gave similar but somewhat weaker
associations. Using PM2.5 estimates as tertiles
(Figure 3 for females) showed that those
exposed to levels > 38 µg/m3 were 2.3 times
more likely to die of CHD than were those
living in areas where concentrations were
≤ 25 µg/m3 (p-value for trend = 0.007). After
adjusting for O3 in two-pollutant models, the
risk estimates for PM2.5 increased to 2.03 and
Fatal CHD and association with ambient particles 
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Table 1. Selected characteristics of study population at baseline.
Male (n = 1,149) Female (n = 2,090)
Cases Noncases Cases Noncases
Characteristic (n = 95) (n = 1,054) (n = 155) (n = 1,935)
Age [years (mean ± SD)] 67.6 ± 11.5 55.8 ± 12.9** 72.3 ± 8.9 56.6 ± 13.4**
Years of education (mean ± SD) 13.5 ± 3.5 14.6 ± 3.2* 12.6 ± 2.8 13.4 ± 2.6**
Never smokers 51 (53.7) 717 (68.0)* 133 (85.8) 1,655 (85.5)
BMI at or above median 46 (48.4) 477 (45.3) 76 (49.0) 875 (45.2)
Meat consumptiona,b
< 1 week 40 (42.1) 496 (47.1) 88 (56.8) 913 (47.2)
1 week 50 (52.6) 516 (49.0) 57 (36.8) 917 (47.4)
Total exercise
Low 25 (26.3) 344 (32.6) 67 (43.2) 937 (48.4)
Moderate and high 70 (73.7) 709 (67.3) 83 (53.5) 990 (51.2)
History of hypertension 32 (33.7) 171 (16.2)** 70 (45.2) 444 (22.9)**
ETS 57 (60.0) 619 (58.7) 77 (49.7) 1,208 (62.5)*
Nutsa
≤ 2/month 29 (30.5) 331 (31.4) 60 (38.7) 684 (35.3)
1–4/week 37 (38.9) 428 (40.6) 51 (32.9) 736 (38.0)
≥ 5/week 23 (24.2) 255 (24.2) 33 (21.3) 397 (20.5)
Watera,c
≤ 2 glasses 6 (6.3) 119 (11.3) 26 (16.8) 351 (18.1)
3–4 glasses 44 (46.3) 369 (35.0) 49 (31.6) 708 (36.6)
≥ 5 glasses 42 (44.2) 546 (51.8) 79 (51.0) 833 (43.0)
Postmenopausal 138 (89.0) 1,323 (68.4)**
HRT in postmenopausal females 20 (14.5) 431 (32.6)**
Values are presented as no. (%) or mean ± SD.
aSome columns do not add to 100% because of missing data. bSignificant at p < 0.01 for females only. cSignificant at
p < 0.05 for males only. *p < 0.01, **p < 0.001.
Table 2. Descriptive statistics and correlations between long-term averages of pollutants estimated for
study participants, 1973 through month of censoring, females and males combined (n = 3,239).
PM10 (µg/m3)P M 2.5 (µg/m3)P M 10–2.5 (µg/m3)O 3 (ppb) NO2 (ppb) SO2 (ppb)
Mean ± SD 52.6 ± 16.9 29.0 ± 9.8 25.4 ± 8.5 26.2 ± 7.3 34.9 ± 9.7 4.5 ± 2.7
PM10 1.00 0.83* 0.91* 0.79* 0.50* 0.36*
PM2.5 1.00 0.59* 0.60* 0.25* 0.30*
PM10–2.5 1.00 0.75 0.51* 0.35*
O3 1.00 0.22* 0.11*
NO2 1.00 0.70*
SO2 1.00
*p < 0.01.5.35 in the medium and highest tertiles,
respectively (p-value for trend = 0.006).
No significant associations were found
between any of the gaseous pollutants and fatal
CHD in either the age-adjusted or multivari-
able-adjusted analyses in single-pollutant or in
two-pollutant models with PM. However, the
association with NO2 was elevated for both
males and females in single-pollutant models
(Table 3). In males, no association was found
between particulate pollutants and fatal CHD
either as continuous or as categorical (tertiles)
variables in single- or two-pollutant models
(Tables 3, 4).
Discussion
Most studies of the association between ambi-
ent particulate air pollution and cardiovascu-
lar disease (CVD) have been limited to effects
of short-term increases in PM on hospital
admissions for CVD (Zanobetti et al. 2000)
and total mortality (Dominici et al. 2003;
Chen et al.
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Table 4. Age-adjusted and multivariable-adjusted RRs of fatal CHD for speciﬁc PM components: two-pollutant models.
Postmenopausal females,
Age adjusteda Multivariable adjustedb Multivariable adjustedc multivariable adjustedc
Pollutant PM Gas Cases RRd (95% CI) Cases RRd (95% CI) Cases RRd (95% CI) Cases RRd (95% CI)
Females PM10 +O 3 92 1.33 (1.12–1.59) 92 1.45 (1.21–1.74) 92 1.45 (1.31–1.61) 80 1.52 (1.37–1.69)
NO2 92 1.11 (0.97–1.26) 92 1.21 (1.05–1.40) 92 1.21 (1.00–1.46) 80 1.29 (1.06–1.57)
SO2 87 1.15 (1.02–1.31) 87 1.27 (1.10–1.47) 87 1.27 (1.08–1.50) 77 1.33 (1.11–1.59)
PM2.5 +O 3 92 1.61 (1.17–2.22) 92 1.99 (1.37–2.88) 92 2.00 (1.51–2.64) 80 1.95 (1.52–2.50)
NO2 92 1.18 (0.95–1.47) 92 1.39 (1.08–1.80) 92 1.40 (1.04–1.87) 80 1.46 (1.13–1.89)
SO2 87 1.36 (1.05–1.74) 87 1.50 (1.15–1.97) 87 1.51 (1.17–1.95) 77 1.51 (1.19–1.92)
PM10–2.5 +O 3 92 1.47 (1.10–1.96) 92 1.62 (1.21–2.17) 92 1.62 (1.31–2.01) 80 1.85 (1.50–2.29)
NO2 92 1.19 (0.92–1.54) 92 1.35 (1.03–1.76) 92 1.34 (0.94–1.94) 80 1.59 (1.07–2.36)
SO2 87 1.31 (1.03–1.68) 87 1.49 (1.15–1.93) 87 1.49 (1.12–1.99) 77 1.68 (1.20–2.35)
Males PM10 +O 3 53 0.97 (0.78–1.20) 53 0.96 (0.77–1.19) 53 0.96 (0.87–1.05)
NO2 53 0.90 (0.76–1.07) 53 0.91 (0.76–1.09) 53 0.91 (0.78–1.07)
SO2 51 0.92 (0.78–1.09) 51 0.93 (0.78–1.11) 51 0.93 (0.78–1.11)
PM2.5 +O 3 53 0.92 (0.65–1.29) 53 0.91 (0.64–1.30) 53 0.91 (0.78–1.06)
NO2 53 0.82 (0.61–1.10) 53 0.85 (0.63–1.15) 53 0.85 (0.70–1.04)
SO2 51 0.86 (0.65–1.14) 51 0.88 (0.65–1.19) 51 0.88 (0.73–1.07)
PM10–2.5 +O 3 53 1.01 (0.67–1.51) 53 0.97 (0.64–1.46) 53 0.97 (0.74–1.26)
NO2 53 0.86 (0.62–1.20) 53 0.87 (0.62–1.23) 53 0.87 (0.60–1.26)
SO2 51 0.90 (0.64–1.27) 51 0.89 (0.63–1.27) 51 0.85 (0.55–1.32)
aAge adjusted with sandwich variance estimate. bAdjusted for smoking status (past vs. never), years of education, BMI (below vs. at or above median), meat consumption (< 1/week vs.
≥ 1/week), calendar time. cModel “b” with sandwich variance estimate. dRR was calculated for an increase of 10 µg/m3 in concentration of the speciﬁc PM components.
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Figure 2. Frequency distribution of mean ambient concentration of (A) PM10, (B) PM2.5 , and (C) PM10–2.5, 1973 to censoring month; n = 3,239. Note that the x-axis
scales differ among the three panels.
Table 3. Age-adjusted andmultivariable-adjusted RRs of fatal CHD for speciﬁc PM components: single-pollutant models.
Postmenopausal females,
Age adjusted Multivariable adjusteda Multivariable adjustedb multivariable adjustedb
Pollutant Increment Cases RR (95% CI) Cases RR (95% CI) Cases RR (95% CI) Cases RR (95% CI)
Females PM10 10 µg/m3 92 1.11 (0.98–1.26) 92 1.22 (1.06–1.40) 92 1.22 (1.01–1.47) 80 1.30 (1.08–1.57)
PM2.5 10 µg/m3 92 1.19 (0.96–1.47) 92 1.42 (1.11–1.81) 92 1.42 (1.06–1.90) 80 1.49 (1.17–1.89)
PM10–2.5 10 µg/m3 92 1.20 (0.95–1.53) 92 1.38 (1.07–1.77) 92 1.38 (0.97–1.95) 80 1.61 (1.12–2.33)
O3 10 ppb 92 0.89 (0.67–1.18) 92 0.97 (0.71–1.32) 92 0.97 (0.68–1.38) 80 1.07 (0.73–1.59)
NO2 10 ppb 92 1.09 (0.88–1.35) 92 1.17 (0.92–1.49) 92 1.17 (0.98–1.40) 80 1.20 (1.01–1.44)
SO2 1 ppb 87 0.93 (0.87–1.01) 87 0.94 (0.85–1.04) 87 0.94 (0.81–1.08) 77 0.94 (0.80–1.11)
Males PM10 10 µg/m3 53 0.95 (0.81–1.11) 53 0.94 (0.80–1.11) 53 0.94 (0.82–1.08)
PM2.5 10 µg/m3 53 0.89 (0.69–1.17) 53 0.90 (0.67–1.19) 53 0.90 (0.76–1.05)
PM10–2.5 10 µg/m3 53 0.93 (0.68–1.29) 53 0.92 (0.67–1.28) 53 0.92 (0.66–1.29)
O3 10 ppb 53 0.87 (0.58–1.29) 53 0.89 (0.59–1.33) 53 0.89 (0.60–1.30)
NO2 10 ppb 53 1.24 (0.94–1.64) 53 1.16 (0.86–1.56) 53 1.16 (0.89–1.51)
SO2 1 ppb 51 1.06 (0.98–1.14) 51 1.02 (0.92–1.13) 51 1.02 (0.94–1.11)
aAdjusted for smoking status (past vs. never), years of education, BMI (below vs. at or above median), meat consumption (< 1/week vs. ≥ 1/week), calendar time. bModel “b” with sandwich
variance estimate.Samet et al. 2000). Of the particulate pollu-
tants, PM2.5 seems to show the strongest asso-
ciation with CVD outcomes (Pope et al.
2002, 2004a).
The Six Cities and the ACS studies have
reported a positive association between CPD
and cardiovascular deaths and long-term expo-
sure to ambient PM. The association was
strongest for ﬁne particles, with RRs varying
between 1.06 for CPD deaths (Pope et al.
2002) and 1.12 for cardiovascular deaths (Pope
et al. 2004a) for each increment of 10 µg/m3
after adjusting for age, sex, diet, and other
demographic covariates. When comparing
most-polluted with least-polluted areas, the RR
for CPD death was 1.31 for a difference of
24.5 µg/m3 in the ACS study (Pope et al.
1995) and 1.37 for a difference of 18.6 µg/m3
in the Six Cities Study (Dockery et al. 1993).
Pope et al. (2004a) reported a somewhat
higher risk estimate for mortality from IHD,
with an RR of 1.18 for an increment of 10
µg/m3, and concluded that “predominant PM
mortality associations” were with IHD. The
effect of ﬁne particles on CPD mortality has
not been reported from AHSMOG to date.
For PM10 and CPD mortality, no signiﬁcant
relationships were found, but males had higher
estimates than did females (Abbey et al. 1999).
Two European cohort studies have both
looked at trafﬁc-related pollution (Hoek et al.
2002; Nafstad et al. 2004). Hoek et al. (2002)
found that persons living near a major road
had a 1.95 greater risk of CPD death than did
others and, that for each increase of 10 µg/m3
in black smoke, the RR increased by 34%.
Among Norwegian men, Nafstad et al. (2004)
found that for each increase of 10 µg/m3 in
nitrogen oxides (markers of trafﬁc pollution),
the risk increased by 8% for fatal IHD and by
16% for respiratory deaths.
We found signiﬁcant relationships between
ambient PM and fatal CHD only in females.
To our knowledge, no other cohort study on
the health effects of ambient air pollution has
reported sex-speciﬁc risks for CHD mortality.
Therefore, we cannot readily compare our
ﬁndings with others. However, the ACS study
did ﬁnd a slightly higher, although not signiﬁ-
cant, risk of CPD mortality among never-
smoking females versus males in the most-
polluted cities compared with the least pol-
luted (RR = 1.57 in females vs. 1.24 in males)
(Pope et al. 1995). As far as we have been able
to assess, neither the Six Cities Study nor the
Dutch study (Hoek et al. 2002) has reported
sex-specific findings on CPD mortality. The
Norwegian cohort included only males
(Nafstad et al. 2004), as did the male U.S. vet-
erans cohort mortality study (Lipfert et al.
2000). In a study of short-term effects, Peters
et al. (1997) reported a stronger effect of TSPs
on blood viscosity in females than males dur-
ing episodes of high air pollution in Augsburg,
Germany.
Several experimental studies of pulmonary
deposition of inhaled particles in healthy
adults showed that particle deposition charac-
teristics differ between males and females
under controlled breathing conditions. Kim
and Hu (1998) found that deposition in
females is greater than that in males and that
the deposition was more localized within the
lung in females. The authors suggest that
regional deposition enhancement in women
may lead to a greater health risk in females
than in males. This is consistent with the
hypothesized mechanism in which the deposi-
tion of particles in the lung could elicit
inflammatory responses resulting in a sys-
temic signal (Seaton et al. 1995).
An experimental study of 50 persons
(Sorensen et al. 2003) showed signiﬁcant posi-
tive associations between personal PM2.5 expo-
sure and oxidation products [e.g., plasma
malondialdehyde, red blood cells (RBCs), and
hemoglobin concentrations] in females but not
in males. The authors suggest that females pos-
sibly are more sensitive to airborne pollution
than are males because they have fewer RBCs
and thus may be more sensitive to toxicologic
inﬂuences of air pollutants.
A recent study supporting our sex-differ-
ential findings assessed the relationship
between ambient levels of PM2.5 at place of
residence and degree of intima media thick-
ness as measured by ultrasound (Künzli et al.
2005). Cross-sectional analyses of baseline
data from two clinical trials in Los Angeles
showed that the association was statistically
significant among women but not among
men. Also, the associations were stronger
among older persons who had never smoked
or who reported using lipid-lowering treat-
ment at baseline. The strongest association,
however, was found among older women
(≥ 60 years of age). These findings corrobo-
rate with our findings from AHSMOG,
which is also an older population, with mean
age at fatal CHD of 67.6 years in men and
72.3 years in women.
Our findings and those of other studies
show that particulate air pollution seems to
have a stronger effect on fatal CHD than on
other fatal CPD end points. The ACS study
found a somewhat higher RR associated with
an increase in PM2.5 of 10 µg/m3 for fatal
IHD (RR = 1.18; 95% CI, 1.14–1.23) (Pope
et al. 2004a) than what they had previously
found for CPD mortality (RR = 1.09; 95%
CI, 1.03–1.16) (Pope et al. 2002). In females,
our findings for fatal CHD and PM are
stronger than those we have previously
reported for CPD mortality in the total
AHSMOG cohort (Abbey et al. 1999) and in
the airport cohort (McDonnell et al. 2000).
Also, in a previous report we found positive
associations with CPD mortality only in males
(Abbey et al. 1999). In extended follow-up of
CPD mortality in the total AHSMOG cohort
through 1998 using the same models as previ-
ously, we continue to ﬁnd a slightly stronger
association in males than in females (unpub-
lished data). However, when we exclude base-
line CHD, stroke, and diabetes, these sex
differences disappear, and when we limit our
analyses to the airport cohort, CPD mortality
is actually significantly increased in females
but not in males (RR = 1.14 vs. 1.02 in
males). These ﬁndings warrant further study
of the effect of PM in sensitive subgroups
and in densely populated areas (e.g., airport
cohort) versus less densely populated areas. It
also suggests that health effects of air pollution
are different in males and females.
Even though we found the strongest associ-
ation with PM2.5, the coarse fraction was also
associated with signiﬁcant risk. One possible
explanation for the higher risk estimates for all
three PM fractions in our study could be more
precise estimates of ambient air pollution and
thus less exposure misclassiﬁcation. AHSMOG
is the only study with monthly estimates of
ambient air pollution for each subject through-
out the entire follow-up period. Other reasons
could be the homogeneity of the population
(see “Strengths and limitations,” below).
Because different components of air pollu-
tion frequently occur together and are highly
correlated (Table 2), the U.S. Environmental
Protection Agency (EPA) has suggested that
the association observed with PM could
instead be due to gaseous pollutants (U.S. EPA
1989). We found no significant association
between fatal CHD and gaseous pollutants in
single- or two-pollutant models. However, in
two-pollutant models, both O3 and SO2
strengthened the relationship between PM and
fatal CHD, whereas NO2 had no effect. The
modifying effect of O3 can possibly be
explained by findings indicating that lung
epithelial permeability increases with exposure
to O3 (Blomberg et al. 2003), thus making
the body more susceptible to intrusion of par-
ticulate matter. The proposed mechanisms for
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Figure 3. RR of fatal CHD and tertiles of PM2.5 mean
concentration in single- and two-pollutant models
(PM2.5 + O3); all females.the observed cardiovascular effects of particu-
lates have been discussed in detail in a state-
ment from the American Heart Association
(Brook et al. 2004). Several pathways may be
involved, but initiation of pulmonary and sys-
temic oxidative stress and inflammation by
components of the different PM particles
seems to be the most accepted. The resulting
cascades of physiologic responses are believed
to be able to jointly initiate processes that
ultimately lead to a CHD event. Elevated
ambient PM2.5 levels have been shown to be
associated with cardiac autonomic function
(Peters et al. 2000), heart rate and heart rate
variability (Pope et al. 2004b), CRP levels
(Riediker et al. 2004), and changes in blood
viscosity favoring coagulation (Peters et al.
1997; Seaton et al. 1995). Several authors
have suggested that risk of CVD may be medi-
ated, at least partly, through increased con-
centrations of plasma ﬁbrinogen, possibly due
to an inflammatory reaction caused by air
pollution (Koenig et al. 1998). Fibrinogen is
an important determinant of plasma viscosity
and an independent risk factor for CHD
(Koenig et al. 1998). Numerous animal mod-
els corroborate the ﬁndings in humans of an
effect of PM on heart rate (Chang et al. 2004),
blood viscosity (Coates and Richardson 1978),
and pulmonary inﬂammation (Wichers et al.
2004).
These pathways are very similar to
those suggested for the effect of cigarette
smoking on risk of CHD, such as elevated
inflammatory markers, especially CRP levels
(Panagiotakos et al. 2004), fibrinogen and
white cell counts (Panagiotakos et al. 2004),
blood viscosity (Frohlich et al. 2003), heart
rate (Bolinder and de Faire 1998), and oxida-
tive stress (Guthikonda et al. 2004). Smoking
also has been found to trigger acute vasocon-
striction and thus the enhanced development
of atherosclerosis in the systemic vasculature
(Kiechl et al. 2002). Finally, in studies of the
effect of smoking and ETS, Diez-Roux et al.
(1995) and Howard et al. (1994) have reported
clear effects on intima media thickness pro-
gression over time and on arterial wall stiffness
(Mack et al. 2003).
Strengths and limitations. Because all sub-
jects in AHSMOG are nonsmokers, our
results are free from the confounding of active
cigarette smoking. We had detailed informa-
tion about ETS and have been able to adjust
for this effect. Any modifying effect of alcohol
is also eliminated because virtually everyone
abstains from alcohol. Because AHSMOG
has extensive information on lifestyle, we
were able to adjust for the effects of a number
of such factors, including dietary factors,
found to be associated with CHD in this
cohort. This adjustment actually strengthened
the associations between PM and fatal CHD
in females but not in males.
Although we have shown cardiovascular
effects of particulate air pollution in this study,
we have unknown amounts of measurement
error in both the estimated long-term ambient
concentrations of pollutants and other covari-
ates. One source of measurement error derives
from interpolating ambient concentrations
(PM10, O3, NO2, SO2) from ﬁxed-site moni-
toring stations to ZIP code centroids of work
and home locations of study participants
(Abbey et al. 1991, 1995a). Another source of
measurement error is that ambient PM2.5 con-
centration was not measured directly for the
duration of this study, but estimated from air-
port visibility, temperature, and humidity
(Abbey et al. 1995b). The precision of the
PM10–2.5 is unknown because it is calculated
as the difference between PM10 and PM2.5.
Use of ambient concentrations rather than
measures of personal exposure could be one
limitation in this study, but it is unlikely that
we have selective bias in the females only.
Further, we cannot rule out the possibility that
the observed sex difference in effect could be
due to measurement error. Males, more than
females, reported working > 5 miles from their
residence and thus may have spent more time
in heavy traffic (more commutes and longer
commuter distances). We have not been able
to take this into consideration when estimat-
ing each subject’s ambient air pollution levels.
Conclusions
In summary, in this study we found an elevated
risk of fatal CHD associated with ambient levels
of PM10, PM10–2.5, and PM2.5 in females but
not in males. The risk estimates were strength-
ened when adjusting for gaseous pollutants and
were highest for PM2.5. Our ﬁndings are in line
with ﬁndings by others of an effect of PM on
CPD mortality, but are of greater magnitude,
possibly because the outcome was limited to
fatal CHD with better control of confounding
factors such as alcohol and tobacco.
Further studies are needed from larger
cohorts and/or with longer follow-up to sup-
port our ﬁndings of a sex-differential effect of
PM on risk of fatal CHD. Developing more
accurate ways to assess an individual’s expo-
sure to ambient levels of PM will improve
precision of risk estimates. Further, it is
important to study whether the effects of air
pollution are reversible in a manner similar to
that found when smokers stop smoking. The
effect of different exceedance frequencies
should also be explored as well as the effect of
different chemical compositions of PM.
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